Il-6 Jak Stat3
Il-6 Jak Stat3 - Related Videos
11:19
Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
0 Views •
Cited by 2 •
2016
Tandem splicing events occur at sites less than 12 nucleotides apart. Quantifying ratios of such splice variants is feasible using an absolute quantitative PCR approach. This manuscript describes how splice variants of the gene STAT3, in which two splicing events results in Serine-701 inclusion/exclusion and α/β C-termini, can be quantified.
01:20
The JAK-STAT Signaling Pathway
0 Views •
2023
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
08:42
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
0 Views •
Cited by 4 •
2020
This protocol describes a canonical method to understand the critical genes controlling osteoclast activity in vivo. This method uses a transgenic mouse model and some canonical techniques to analyze skeletal phenotype.
04:21
Generating the 6-hydroxydopamine Rat Model of Parkinson's Disease
0 Views •
2025
This video demonstrates a procedure to create a rat model of Parkinson's disease by injecting the neurotoxin 6-hydroxydopamine (6-OHDA) into the brain. The neurotoxin infusion into the medial forebrain bundle (MFB) specifically targets dopaminergic neurons responsible for motor control, leading to their destruction and replicating Parkinson's disease symptoms.
01:27
Sensorimotor Stage II: Substages 4 to 6
0 Views •
2026
Piaget’s sensorimotor stage describes cognitive development from birth to approximately two years. During this stage, infants progress from reflexive behavior toward intentional action and early symbolic thought. Substages four through six show major advances in problem-solving, experimentation, and mental representation.Substage 4: Coordination of Secondary Circular ReactionsFrom approximately 8 to 12 months, infants begin coordinating previously learned behaviors to achieve specific goals.
FAQs
STAT3 nuclear entry is the key step that converts an extracellular signal into a transcriptional response. After IL-6 engages its receptor and gp130, JAK activity leads to STAT3 activation; STAT3 dimers then move into the nucleus and alter gene transcription. This explains how receptor engagement can influence inflammation, cell survival, and tissue repair.
Gp130 functions as the coreceptor that helps transmit the IL-6 signal to intracellular Janus kinases. Its participation links cytokine recognition at the cell surface with receptor phosphorylation and subsequent STAT3 activation. Because this relay connects the external inflammatory cue to nuclear gene regulation, gp130 is an important component when researchers analyze pathway activity or therapeutic targets.
The pathway can support useful responses to infection and injury, but prolonged activation changes its medical significance. Continued signaling may sustain chronic inflammation and contribute to autoimmune disease or tumor progression rather than allowing the response to resolve. This distinction makes signaling duration an important consideration when interpreting pathway activity in disease research.
A medical investigation can examine IL-6, JAK, or STAT3 activity and then relate those measurements to inflammation, immune responses, cell survival, or tissue repair. Researchers can also study what changes when one of these pathway components is targeted. Together, these approaches help connect molecular signaling with disease mechanisms and evaluate possible anti-inflammatory or immunomodulatory strategies.
The pathway is relevant across both protective and pathological settings. Researchers may examine its role in responses to infection or injury, where signaling can support immune coordination and tissue repair, as well as in chronic inflammation, autoimmune disease, and tumor progression. Comparing these contexts helps clarify when pathway activity is beneficial and when persistent signaling may promote disease.
Targeting different points in the pathway can help researchers determine how cytokine signaling contributes to a disease process. Studying IL-6, JAK, or STAT3 separately may identify which part of the signaling system is most relevant to inflammation or immune dysregulation. This work supports development of anti-inflammatory and immunomodulatory therapies and provides a framework for evaluating their biological rationale.